Essential Thrombocythemia Characterization: Mutational, Cytokine, and Thrombotic Profiling

Hernandez-Matias L; Maysonet-Cruz J; Calzada-Jorge N; Pérez-Donato L; Torres Rivera W; Ramírez-Rodríguez J; Laureano-Torres F; Méndez LB; Ríos O; Menéndez-Pérez J; Washington AV*; Hunter-Mellado R

Essential Thrombocythemia Characterization: Mutational, Cytokine, and Thrombotic Profiling

Research Article Volume 2 Issue 1

Hernandez-Matias L, Maysonet-Cruz J, Calzada-Jorge N, Pérez-Donato L, Torres Rivera W, Ramírez-Rodríguez J, Laureano-Torres F, Méndez LB, Ríos O, Menéndez-Pérez J, Washington AV^* and Hunter-Mellado R

Corresponding Author: Hunter-Mellado R

View PDF View Journal

Abstract

Essential Thrombocythemia (ET) is characterized by a persistent thrombocytosis associated with mutations in Janus Kinase 2 (JAK2V617F), Myeloproliferative Leukemia protein (MPL), and/ or Calreticulin (CALR). Although ET mutational background has been defined for some

Article Information

Journal	SF Journal of Hematology and Oncology
Article Type	Research Article
Volume	2
Issue	1